OLVIG
BSX icon

Oliver Lagore Vanvalin Investment Group’s Boston Scientific BSX Stock Holding History

Oliver Lagore Vanvalin Investment Group’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		$37.4K Buy
+371
New +$37.5K 0.01% 283
2024
Q4 		$45.8K Sell
513
-95
-16% -$8.36K 0.01% 260
2024
Q3 		$51K Buy
608
+55
+10% +$4.34K 0.01% 247
2024
Q2 		$42.6K Sell
553
-375
-40% -$27.4K 0.01% 256
2024
Q1 		$63.6K Sell
928
-100
-10% -$6.43K 0.02% 224
2023
Q4 		$59.4K Buy
1,028
+136
+15% +$7.26K 0.02% 202
2023
Q3 		$47.1K Buy
892
+81
+10% +$4.25K 0.02% 244
2023
Q2 		$43.9K Sell
811
-158
-16% -$8.25K 0.02% 265
2023
Q1 		$48.5K Buy
969
+150
+18% +$7.07K 0.02% 195
2022
Q4 		$37.9K Sell
819
-16
-2% -$693 0.02% 208
2022
Q3 		$32K Hold
835
– – 0.02% 205
2022
Q2 		$31K Buy
835
+85
+11% +$3.46K 0.02% 224
2022
Q1 		$34K Buy
+750
New +$32.5K 0.02% 203

Other funds holding BSX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Oliver Lagore Vanvalin Investment Group's BSX Position: Q2 2025 in Review

Oliver Lagore Vanvalin Investment Group opened a new position in Boston Scientific (BSX) in Q2 2025: 371 shares worth $37.4K. The stake represents 0.01% of the portfolio and ranks #283 among its holdings. This is a return to the name: Oliver Lagore Vanvalin Investment Group previously reported a position in BSX as recently as Q4 2024.

Oliver Lagore Vanvalin Investment Group first reported a position in BSX in Q1 2022 and has held it in 13 quarters since. The position peaked at $63.6K in Q1 2024. 1,687 funds tracked by Wall St. Rank hold BSX as of Q2 2025.

  • Oliver Lagore Vanvalin Investment Group held 371 shares of Boston Scientific worth $37.4K as of Q2 2025.
  • Boston Scientific was a new Oliver Lagore Vanvalin Investment Group position in Q2 2025.
  • Boston Scientific made up 0.01% of Oliver Lagore Vanvalin Investment Group's portfolio in Q2 2025, its #283 holding.
  • Oliver Lagore Vanvalin Investment Group first reported a position in Boston Scientific in Q1 2022 and has held it in 13 quarters since.
  • Oliver Lagore Vanvalin Investment Group's Boston Scientific position peaked at $63.6K in Q1 2024.
  • 1,687 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2025.

Based on Oliver Lagore Vanvalin Investment Group's 13F filing for Q2 2025, filed 10 Jul 2025.